Humacyte

HUMACYTE INC

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

GameStop Corp.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

BHIL

BSGM

CISO

CLEU

GDHG

HUMA

IMTE

NYXH

ORKA

PTPI

RAPP

SURG

THTX

TXMD

WINT

ZYBT

El premercado de hoy revela fuertes movimientos bursátiles tras informes financieros y aprobaciones clave en sectores críticos.

Las acciones de GameStop (GME) suben alrededor del 13%; Aquí están 20 acciones que se mueven en el premercado

AADI

APTO

CADL

CARA

MESO

MOBX

MTEM

NVNI

OCEA

PRFX

QUBT

ZCAR

FedEx sube un 8,7% con resultados sólidos y una nueva estrategia. Descubre otras acciones destacadas en premercado hoy.

Las acciones de FedEx (FDX) suben alrededor de un 9%; 20 acciones que se mueven en premercado

Earnings

Equities

Futures

Economics

Federal Reserve

Los futuros caen ante la &#34;Triple Brujería&#34; y nuevos datos de inflación. ¿Qué dicen los analistas sobre el mercado?

Futuros de EE.UU. caen antes de datos clave de inflación y Triple Brujería

Humacyte Inc

Humana Inc

HUMANOID GLOBAL HLDGS CP by HUMANOID GLOBAL HLDGS CORP.

Humanoid Global Holdings Corp

Humankind US Stock ETF

HUMAN PHEROMONE SCIENCE by Human Pheromone Sciences, Inc.

Human - United States dollar

HUMAN HOLDINGS CO LTD by Human Holdings Co., Ltd.

Human Holdings Co Ltd

HUMAN UNITEC INTL INC by Human Unitec International, Inc.

Human Unitec International Inc

Humanigen Inc

Humanscape

Humatech Inc

Health Care

Press Releases

General

Results from Humacyte's V007 Pivotal Phase 3 AV Access Study Highlighted by Presentation at the Society for Vascular Surgery Meeting

Humacyte announces Symvess™ ECAT Approval from U.S. Defense Logistics Agency

Humacyte Announces First Symvess™ Sale to Military Treatment Facility

Humacyte to Present Second Quarter Financial Results and Provide Corporate Update on August 11, 2025

Humacyte Announces Second Quarter 2025 Financial Results and Provides Business Update

Humacyte Announces Publication of Outcomes for Patients with Hospital-Acquired Vascular Complications Treated with Symvess™

Humacyte Announces Publication of Preclinical Data on Use of the CTEV as a Coronary Artery Bypass Graft (CABG)

Penny Stocks

Humacyte Announces Expansion of Intellectual Property for Pipeline Products with Granting of New U.S. Patent for Bioengineered Esophagus

Humacyte Announces Publication of Long-Term Results for Ukrainian Patients Treated in Real-World Combat Setting with Symvess™

Humacyte Announces Pricing of $60.0 Million Oversubscribed Registered Direct Offering

AC Immune

Aldeyra Therapeutics, Inc. - Common Stock

Aldeyra Therapeutics

Alector

Allogene Therapeutics, Inc. - Common Stock

Allogene Therapeutics

Altimmune

Annexon

Candel Therapeutics

Capricor Therapeutics, Inc. - Common Stock

Capricor Therapeutics

DiaMedica Therapeutics Inc. - Common Stock

DiaMedica Therapeutics

Design Therapeutics

Enanta Pharmaceuticals, Inc. - Common Stock

Enanta Pharma

Eupraxia Pharmaceuticals Inc. - Common Stock

Eupraxia Pharmaceuticals

Galectin Therapeutics Inc. - Common Stock

Galectin Therapeutics

Immutep Limited - American Depositary Shares

Immutep

Immuneering Corporation - Class A Common Stock

Immuneering

Kyverna Therapeutics, Inc. - Common Stock

Kyverna Therapeutics

Lyell Immunopharma

Mereo BioPharma Group plc - American Depositary Shares

Mereo BioPharma Group

PepGen

ProQR Therapeutics N.V. - Ordinary Shares

ProQR Therapeutics

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics

Tectonic Therapeutic, Inc. - Common Stock

Tectonic Therapeutic

Tenaya Therapeutics

Vanda Pharmaceuticals Inc. - Common Stock

Vanda Pharmaceuticals

Voyager Therapeutics, Inc. - Common Stock

Voyager Therapeutics

BTIG

D. Boral Capital

Barclays

TD Cowen

HC Wainwright & Co.

Comments

Humacyte

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL